Suppr超能文献

氨甲环酸在全肩关节置换术中减少失血的疗效:一项荟萃分析。

The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis.

作者信息

He Jing, Wang Xi-E, Yuan Guo-Hong, Zhang Lian-Hai

机构信息

Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University Surgical Department, Jinan Infectious Diseases Hospital, Jinan Department of Anesthesiology, Shouguang City People's Hospital, Shouguang City, Shandong Emergency Department, Zaozhuang Municipal Hospital, Zaozhuang, China.

出版信息

Medicine (Baltimore). 2017 Sep;96(37):e7880. doi: 10.1097/MD.0000000000007880.

Abstract

BACKGROUND

The purpose of this meta-analysis is to compare the efficacy of tranexamic acid (TXA) versus placebo after a total shoulder arthroplasty (TSA).

METHODS

In April 2017, a systematic computer-based search was conducted in the databases of PubMed, Embase, Web of Science, Cochrane Library, and Google. Studies comparing TXA versus placebo in reducing blood loss after TSA were included. The endpoints were the need for transfusion, blood loss in drainage, hemoglobin drop, and total blood loss. Stata 12.0 software was used for the meta-analysis.

RESULTS

Six studies involving a total of 637 patients met the inclusion criteria. The meta-analysis revealed that, compared with control groups, treatment with TXA could decrease the need for transfusion (P < .00001), blood loss in drainage (P = .000), hemoglobin drop (P = .001), and total blood loss (P = .000).

CONCLUSION

TXA can decrease the need for transfusion as well as total blood loss in TSA patients. There was a negative correlation between the TXA dose and the need for transfusion and blood loss in drainage. Because the administration route and the dose of TXA were different, more studies are needed in order to identify the optimal dose and route.

摘要

背景

本荟萃分析的目的是比较全肩关节置换术(TSA)后氨甲环酸(TXA)与安慰剂的疗效。

方法

2017年4月,在PubMed、Embase、Web of Science、Cochrane图书馆和谷歌数据库中进行了基于计算机的系统检索。纳入比较TXA与安慰剂在TSA后减少失血方面的研究。终点指标为输血需求、引流管失血量、血红蛋白下降和总失血量。使用Stata 12.0软件进行荟萃分析。

结果

六项研究共纳入637例患者,符合纳入标准。荟萃分析显示,与对照组相比,TXA治疗可减少输血需求(P<0.00001)、引流管失血量(P = 0.000)、血红蛋白下降(P = 0.001)和总失血量(P = 0.000)。

结论

TXA可减少TSA患者的输血需求和总失血量。TXA剂量与输血需求和引流管失血量之间存在负相关。由于TXA的给药途径和剂量不同,需要更多研究以确定最佳剂量和途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e2f/5604638/d5dff1cd8a84/medi-96-e7880-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验